论文部分内容阅读
目的探究分析欣普贝生在延期和过期妊娠促宫颈成熟引产过程中的应用效果并对其安全性进行评价。方法选择90例延期和过期妊娠孕妇为研究对象,采用随机数字表法将其分为对照组与观察组。对照组患者在生产过程中选用常规药物缩宫素进行催产,观察组患者则选用欣普贝生药物进行催产。在患者用药4、8、12 h后进行两组患者宫颈成熟度评分(Bishop评分)的比较,同时比较两组患者的引产成功情况、剖宫产及羊水污染等指标。结果观察组患者采用欣普贝生药物进行催产后4、8、12 h的宫颈成熟程度优于对照组(P<0.05),引产成功率高于对照组(P<0.05),剖宫产率低于对照组(P<0.05)。两组患者羊水污染发生率比较差异未见统计学意义(P>0.05)。结论采用欣普贝生药物对延期和过期妊娠患者进行促宫颈成熟和引产具有比较重要的意义,对宫颈成熟具有促进作用,使阴道分娩的成功率得到提高。
Objective To explore and analyze the effect of Enxi Bayesian in inducing cervical ripening induced labor in delayed and expired pregnancy and evaluate its safety. Methods 90 pregnant women with postponement and expired pregnancy were selected as the research object, and were divided into control group and observation group by random number table method. The control group of patients in the production process using conventional oxytocin oxytocin, the observation group of patients were selected Yan P bei drugs for oxytocin. Cervical maturity score (Bishop score) was compared between the two groups after 4, 8, and 12 hours of treatment. The success rate of labor induction, cesarean section and amniotic fluid contamination were compared between the two groups. Results In the observation group, the cervical ripening rate at 4, 8, and 12 h after drug-induced seizures was better than that of the control group (P <0.05), and the success rate of induction of labor was higher than that of the control group (P <0.05) Lower than the control group (P <0.05). There was no significant difference in the incidence of amniotic fluid between the two groups (P> 0.05). Conclusion It is of great significance to use Enbebenes drugs to promote cervical ripening and induction of labor in patients with postpartum and postpartum pregnancies, and to promote cervical ripening and improve the success rate of vaginal delivery.